A Phase III, Randomized, Double-Blind, Controlled Study (PEMPHIX) to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. (2020). SKIN The Journal of Cutaneous Medicine, 4(1), S26. https://skin.dermsquared.com/skin/article/view/806